You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 57 No. 4, April 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  History of Neurology: Seminal Citations
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (29)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology, Other
 •Alert me on articles by topic

Manganese Intoxication

Joung-Wook Lee, MD

Arch Neurol. 2000;57:597-599.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Manganese plays an important role as a cofactor in many enzymatic reactions in humans but in excess amounts can cause irreversible nervous system damage.1-2 Although manganism is a rare condition, it can be the cause of complex nervous system symptoms, especially in the setting of environmental exposure.3-4 Specifically, manganese is a well-known cause of dystonic parkinsonism.5 This article highlights several historical descriptions of the clinical manifestations, pathological changes, and attempted therapeutic intervention in manganese intoxication.


CLINICAL DESCRIPTION

In 1837, Couper6 described manganese intoxication in 2 patients:

Their skin is constantly covered with a layer of the oxide, and the air which they breathe is impregnated with a multitude of molecules of this oxide which are introduced into their lungs by respiration. In 1821 a young man apparently in good health, being employed at this work, presented symptoms of paraplegia which becoming worse, forced him at the end of some . . . [Full Text of this Article]

PATHOLOGY

PATHOGENESIS

THERAPEUTIC TRIALS

From the Department of Neurology, College of Medicine, the Catholic University of Korea, Seoul.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Putative proteins involved in manganese transport across the blood-brain barr 1ier
Fitsanakis et al.
Hum Exp Toxicol 2007;26:295-302.
ABSTRACT  

Occupational and other risk factors for hand-grip strength: the Honolulu-Asia Aging Study
Charles et al.
Occup. Environ. Med. 2006;63:820-827.
ABSTRACT | FULL TEXT  

Searching for a relationship between manganese and welding and Parkinson's disease
Jankovic
Neurology 2005;64:2021-2028.
ABSTRACT | FULL TEXT  

The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging
Zecca et al.
Proc. Natl. Acad. Sci. USA 2004;101:9843-9848.
ABSTRACT | FULL TEXT  

Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels
Forton et al.
Gut 2004;53:587-592.
ABSTRACT | FULL TEXT  

Welding-related parkinsonism: Clinical features, treatment, and pathophysiology
Sadak et al.
Neurology 2001;57:1738-1739.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.